Professor Paul Workman appointed Interim Chief Executive of The Institute of Cancer Research 23 May 2014
Statement in response to NICE draft guidance rejecting the use of abiraterone for prostate cancer before chemotherapy 13 May 2014
Statement in response to NICE final draft guidance recommending enzalutamide for prostate cancer 09 May 2014